249 related articles for article (PubMed ID: 11139663)
1. [Horton's disease and hypereosinophilic syndrome: a non-fortuitous association].
Liozon E; Soria P; Gissot V; Loustaud V; Jauberteau MO; Vidal E
Ann Med Interne (Paris); 2000 Nov; 151(7):603-605. PubMed ID: 11139663
[TBL] [Abstract][Full Text] [Related]
2. [Horton's disease and corticosteroid-responsive hearing loss].
Saadoun D; Cacoub P; Costedoat-Chalumeau N; Sbai A; Piette JC
Ann Med Interne (Paris); 2000 Nov; 151(7):600-602. PubMed ID: 11139662
[TBL] [Abstract][Full Text] [Related]
3. [Unusual manifestation of Horton's disease: apropos of 2 case reports].
Boschi A; Vliers S; Lefebvre C
Bull Soc Belge Ophtalmol; 1995; 259():189-95. PubMed ID: 8983534
[TBL] [Abstract][Full Text] [Related]
4. [Endomyocardial disease as the first manifestation of hypereosinophilic syndrome].
Poreba M; Rostoff P; Konduracka E; Pikul P; Rucińska M; Pasowicz M; Piwowarska W
Kardiol Pol; 2010 Apr; 68(4):440-5. PubMed ID: 20425707
[TBL] [Abstract][Full Text] [Related]
5. [Horton's bitemporal arteritis. A case report].
Carmenini G; Martusciello S; Di Maio F; Scioli A; Nicoletti M; Meloni F
Recenti Prog Med; 1992 Oct; 83(10):559-63. PubMed ID: 1462039
[TBL] [Abstract][Full Text] [Related]
6. [Horton's disease presenting as a myocardial infarction].
Zahraoui M; Bennis A; Tahiri A; Chraibi N
Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):10-2. PubMed ID: 12555352
[TBL] [Abstract][Full Text] [Related]
7. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
[TBL] [Abstract][Full Text] [Related]
8. [Late recurrence of Horton's disease with sicca syndrome].
Chagnon JP; Brion N; Yeni P; Barge J; Isoul R; Carbon C
Sem Hop; 1983 Jan; 59(3):189-91. PubMed ID: 6301044
[TBL] [Abstract][Full Text] [Related]
9. Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Queralt C; Grau JM; Urbano-Márquez A; Palacín A; Colomer D; Cid MC
Rheumatology (Oxford); 2004 Mar; 43(3):294-301. PubMed ID: 14679293
[TBL] [Abstract][Full Text] [Related]
10. [Pachymeningitis associated with probable Horton's disease: a case report].
Ait Benhaddou E; Zinebi A; Elhassani M; Raissouni L; Elhassani MR; Benomar A; Yahyaoui M
Rev Neurol (Paris); 2010 Feb; 166(2):253-6. PubMed ID: 19497602
[TBL] [Abstract][Full Text] [Related]
11. [Case of Horton's arteritis with development of simultaneous bilateral amaurosis].
Maggioni F; Trevisan C; Segato T; Zanchin G
Riv Patol Nerv Ment; 1983; 104(1):1-7. PubMed ID: 6678479
[TBL] [Abstract][Full Text] [Related]
12. [Alpha interferon treatment in idiopathic hypereosinophilic syndrome resistant to conventional therapy].
Esteve J; Cervantes F; Bosch F; Cobo F; Montserrat E; Rozman C
Med Clin (Barc); 1996 Mar; 106(8):304-6. PubMed ID: 8667689
[TBL] [Abstract][Full Text] [Related]
13. [Horton's disease: retrospective study of 33 cases and review of the literature].
Piette AM; Dorra M; Betourne C; Levy R; Dechy H; Cassan P; Lang F
Sem Hop; 1982 Dec; 58(48):2819-24. PubMed ID: 6302848
[TBL] [Abstract][Full Text] [Related]
14. Superficial venous thrombophlebitis as the initial manifestation of hypereosinophilic syndrome: study of the first 3 cases.
Terrier B; Piette AM; Kerob D; Cordoliani F; Tancrède E; Hamidou L; Lebbé C; Blétry O; Kahn JE
Arch Dermatol; 2006 Dec; 142(12):1606-10. PubMed ID: 17178987
[TBL] [Abstract][Full Text] [Related]
15. Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome.
Ishii K; Mizuuchi T; Yamamoto Y; Mori H; Tago M; Kato E; Hayashi H; Tahara K; Sawada T
Intern Med; 2020 May; 59(10):1323-1330. PubMed ID: 32101832
[TBL] [Abstract][Full Text] [Related]
16. [Anti-cardiolipin antibodies in Horton's disease].
Liozon F; Jauberteau-Marchan MO; Liozon E; Vidal E
Ann Med Interne (Paris); 1992; 143(7):433-7. PubMed ID: 1300862
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary involvement in idiopathic hypereosinophilic syndrome.
Mirchandani LV; Mandke JV; Joshi JM
J Postgrad Med; 1997; 43(1):23-4. PubMed ID: 10740711
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon.
Butterfield JH
Immunol Allergy Clin North Am; 2007 Aug; 27(3):493-518. PubMed ID: 17868861
[TBL] [Abstract][Full Text] [Related]
19. [Horton's disease].
Liozon E
Rev Prat; 2005 Jan; 55(2):131-2. PubMed ID: 15825992
[No Abstract] [Full Text] [Related]
20. [Recurrent subacute encephalopathy in the framework of idiopathic hypereosinophilic syndrome].
Balestra B; Pedrazzi P; Regli F
Dtsch Med Wochenschr; 1999 Mar; 124(11):321-4. PubMed ID: 10209533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
